- Home
- OTLK vs QMCO Comparison
OTLK vs QMCO Comparison
Compare OTLK & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- QMCO
- Stock Information
- Founded
- OTLK 2010
- QMCO 1980
- Country
- OTLK United States
- QMCO United States
- Employees
- OTLK N/A
- QMCO N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- QMCO Electronic Components
- Sector
- OTLK Health Care
- QMCO Technology
- Exchange
- OTLK Nasdaq
- QMCO Nasdaq
- Market Cap
- OTLK 48.3M
- QMCO 54.7M
- IPO Year
- OTLK 2016
- QMCO N/A
- Fundamental
- Price
- OTLK $2.34
- QMCO $7.55
- Analyst Decision
- OTLK Strong Buy
- QMCO Hold
- Analyst Count
- OTLK 5
- QMCO 2
- Target Price
- OTLK $9.60
- QMCO $19.00
- AVG Volume (30 Days)
- OTLK 1.1M
- QMCO 554.6K
- Earning Date
- OTLK 08-14-2025
- QMCO 08-22-2025
- Dividend Yield
- OTLK N/A
- QMCO N/A
- EPS Growth
- OTLK N/A
- QMCO N/A
- EPS
- OTLK N/A
- QMCO N/A
- Revenue
- OTLK $1,505,322.00
- QMCO $285,865,000.00
- Revenue This Year
- OTLK N/A
- QMCO N/A
- Revenue Next Year
- OTLK $407.74
- QMCO $2.46
- P/E Ratio
- OTLK N/A
- QMCO N/A
- Revenue Growth
- OTLK N/A
- QMCO N/A
- 52 Week Low
- OTLK $0.87
- QMCO $2.22
- 52 Week High
- OTLK $8.32
- QMCO $90.64
- Technical
- Relative Strength Index (RSI)
- OTLK 63.83
- QMCO 39.69
- Support Level
- OTLK $1.95
- QMCO $6.90
- Resistance Level
- OTLK $2.14
- QMCO $8.00
- Average True Range (ATR)
- OTLK 0.17
- QMCO 0.42
- MACD
- OTLK 0.03
- QMCO 0.02
- Stochastic Oscillator
- OTLK 77.62
- QMCO 43.62
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.